Gary Ingenito
Chief Tech/Sci/R&D Officer en CATALYST PHARMACEUTICALS, INC. .
Fortuna: 819 173 $ al 31/03/2024
Perfil
Gary Ingenito is currently the Chief Medical & Regulatory Officer at Catalyst Pharmaceuticals, Inc. He previously held positions as Senior Vice President at inVentiv Health Clinical, Inc. from 2003 to 2005, Senior Vice President-Scientific Affairs at Ontrak, Inc., Chief Clinical & Regulatory Affairs Officer at Angiotech Pharmaceuticals, Inc. from 2005 to 2008, Head-Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc., and Head-Medical Affairs at Sandoz Pharmaceuticals Corp.
Dr. Ingenito has a doctorate degree from Thomas Jefferson University and Sidney Kimmel Medical College, an undergraduate degree from The Johns Hopkins University, and a graduate degree from the University of Miami.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/02/2024 | 51 391 ( 0.04% ) | 819 173 $ | 31/03/2024 |
Cargos activos de Gary Ingenito
| Empresas | Cargo | Inicio |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Antiguos cargos conocidos de Gary Ingenito.
| Empresas | Cargo | Fin |
|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 29/02/2008 |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/01/2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | General Counsel | - |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| ONTRAK, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Gary Ingenito.
| Thomas Jefferson University | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
| University of Miami | Graduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ONTRAK, INC. | Health Services |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
| Sandoz Pharmaceuticals Corp. |
- Bolsa de valores
- Insiders
- Gary Ingenito
